Sonoma Biotherapeutics’ Collaboration Agreement with Regeneron Pharmaceuticals

Pietro Martinoia
Tagged:

Latham & Watkins advised Sonoma Biotherapeutics on the transaction.Sonoma Biotherapeutics, Inc. and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a collaboration to apply their scientific and clinical…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now